Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FWJXW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,830.00 to AmerisourceBergen Drug Corp for the supply of SKYRIZI 360 mg/2.4 mL on-body injectors. This firm fixed price, non-competitive delivery order was issued on August 8, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle valued through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. SKYRIZI is a biologic treatment typically used for dermatological and inflammatory conditions, and this order fulfills medical supply needs within the company's comprehensive portfolio of brand-name pharmaceuticals, generic medications, vaccines, and specialized medical devices. The non-set-aside award reflects AmerisourceBergen's competitive standing within the broader DLA pharmaceutical procurement strategy, which includes plans for multiple regional awards under the forthcoming Pharmaceutical Prime Vendor Global Program Generation V contracts.
Quick answers
Who was awarded contract SPE2DB25FWJXW?
SPE2DB25FWJXW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 8, 2025.
How much is contract SPE2DB25FWJXW worth?
The government has obligated $11,830 on SPE2DB25FWJXW.
Is contract SPE2DB25FWJXW an order under another contract?
Yes. SPE2DB25FWJXW is a delivery order under SPE2DB25D3020, an indefinite delivery contract.
Was contract SPE2DB25FWJXW competed?
The extent of competition for SPE2DB25FWJXW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award